Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in NEWAMSTERDAM PHARMA COMPANY
RA CAPITAL MANAGEMENT, L.P. holds 9.6M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $335M as of 2025-Q4. The position was decreased (-5.8% shares). NAMS represents 3.4% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$335M
Current Shares
9.6M
Total Value Change
+$180.1M
Total Shares Change
+1.5M
Other major holders of NAMS: Capital World Investors, FMR LLC, VIKING GLOBAL INVESTORS LP
Decreased |
| 9.6M |
-5.8% |
| $335M |
| 3.4% |
| $34.74 |
0 |
| 2025-Q3 | Unchanged | 10.1M | 0.0% | $288.4M | 3.6% | $27.52 | 0 |
| 2025-Q2 | Unchanged | 10.1M | 0.0% | $183.6M | 3.1% | $18.57 | 0 |
| 2025-Q1 | Increased | 10.1M | +14.6% | $207.5M | 3.5% | $21.76 | 64 |
| 2024-Q4 | Increased | 8.8M | +9.7% | $227.3M | 3.0% | $25.60 | 62 |
| 2024-Q3 | Unchanged | 8.1M | 0.0% | $133.9M | 1.5% | $16.23 | 0 |
| 2024-Q2 | Increased | 8.1M | +2.5% | $154.9M | 2.0% | $19.21 | 53 |